TBIQYR7637-Global Acute Lymphocytic Leukemia Therapeutics Market Research Report 2019
- TBI110675
- February 14, 2019
- Global
- 98 pages
- QY Market Research
Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells called as lymphocytes in bone marrow. It is a malignant disease in which early precursor lymphoid cells proliferate and replace the normal hematopoietic cells of bone marrow. ALL is the most common type of cancer in children. There is overproduction of lymphoblasts in the bone marrow when a person suffers from ALL that continuously multiply, damaging the bone marrow by preventing the production of normal cells such as red blood cells (RBC) and platelets. Increase in number of lymphoblast in the blood results in the decline of healthy RBCs, white blood cells, and platelets. This leads to anemia, bleeding, and infection. The cancer can spread to the spinal cord and the brain.
The global Acute Lymphocytic Leukemia Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025.
This report focuses on Acute Lymphocytic Leukemia Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Lymphocytic Leukemia Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Erytech Pharma
Talon Therapeutic, Inc
Glaxosmithkline Plc
Sigma-tau Pharmaceuticals, Inc
Genzyme Corporation
Amgen
Bristol-myers Squibb
Novartis
Juno Therapeutics, Inc.
Celgene Corporation
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Oral Administration
Parental Administration
Segment by Application
Biologics
Small Molecule
Ambulatory Clinics
Home Healthcare
Table of Contents
Executive Summary
1 Acute Lymphocytic Leukemia Therapeutics Market Overview
1.1 Product Overview and Scope of Acute Lymphocytic Leukemia Therapeutics
1.2 Acute Lymphocytic Leukemia Therapeutics Segment by Type
1.2.1 Global Acute Lymphocytic Leukemia Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Oral Administration
1.2.3 Parental Administration
1.3 Acute Lymphocytic Leukemia Therapeutics Segment by Application
1.3.1 Acute Lymphocytic Leukemia Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Biologics
1.3.3 Small Molecule
1.3.4 Ambulatory Clinics
1.3.5 Home Healthcare
1.3 Global Acute Lymphocytic Leukemia Therapeutics Market by Region
1.3.1 Global Acute Lymphocytic Leukemia Therapeutics Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Acute Lymphocytic Leukemia Therapeutics Market Size
1.4.1 Global Acute Lymphocytic Leukemia Therapeutics Revenue (2014-2025)
1.4.2 Global Acute Lymphocytic Leukemia Therapeutics Production (2014-2025)
2 Global Acute Lymphocytic Leukemia Therapeutics Market Competition by Manufacturers
2.1 Global Acute Lymphocytic Leukemia Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Acute Lymphocytic Leukemia Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Acute Lymphocytic Leukemia Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Acute Lymphocytic Leukemia Therapeutics Production Sites, Area Served, Product Types
2.5 Acute Lymphocytic Leukemia Therapeutics Market Competitive Situation and Trends
2.5.1 Acute Lymphocytic Leukemia Therapeutics Market Concentration Rate
2.5.2 Acute Lymphocytic Leukemia Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Acute Lymphocytic Leukemia Therapeutics Production Market Share by Regions
3.1 Global Acute Lymphocytic Leukemia Therapeutics Production Market Share by Regions
3.2 Global Acute Lymphocytic Leukemia ...
| read more...
Related Reports
